Valproate Sodium (West-Ward Pharmaceuticals Corp)


Welcome to the PulseAid listing for the Valproate Sodium drug offered from West-Ward Pharmaceuticals Corp. This Anti-epileptic Agent [EPC],Decreased Central Nervous System Disorganized Electrical Activity [PE],Mood Stabilizer [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: West-Ward Pharmaceuticals Corp
NON-PROPRIETARY NAME: Valproate Sodium
SUBSTANCE NAME: VALPROATE SODIUM
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Anti-epileptic Agent [EPC],Decreased Central Nervous System Disorganized Electrical Activity [PE],Mood Stabilizer [EPC]
ROUTE: INTRAVENOUS
DOSAGE FORM: INJECTION
MARKETING CATEGORY NAME: ANDA
START MARKETING DATE: 2013-04-15
END MARKETING DATE: 0000-00-00


Valproate Sodium HUMAN PRESCRIPTION DRUG Details:

Item DescriptionValproate Sodium from West-Ward Pharmaceuticals Corp
LABELER NAME: West-Ward Pharmaceuticals Corp
DEA SCHEDULE:
ACTIVE STRENGTH: 100(mg/mL)
START MARKETING DATE: 2013-04-15
END MARKETING DATE: 0000-00-00
PRODUCT ID: 0143-9637_26f4e03c-2ed7-4188-aadf-fc634fe85f6f
PRODUCT NDC: 0143-9637
APPLICATION NUMBER: ANDA078523

Other VALPROATE SODIUM Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
AbbVie Inc.Depacon
Fresenius Kabi USA, LLCValproate Sodium
West-Ward Pharmaceuticals CorpValproate Sodium